Strassel C, Lanza F, Gachet C
Inserm, EFS Grand Est, BPPS UMR-S 949, FMTS, université de Strasbourg, 67000 Strasbourg, France.
Bull Acad Natl Med. 2020 Dec;204(9):971-980. doi: 10.1016/j.banm.2020.10.002. Epub 2020 Oct 14.
Blood platelets are anucleated elements of the blood. With a diameter of 2 to 3 μm, they are the smallest elements of blood. While their main role is to stop or prevent bleeding, they are also involved in other functions, such as immunity, inflammation or tumour progression. The development of biotechnology and the knowledge acquired about the mechanisms regulating the biogenesis of platelets makes the production of cultured platelets a viable option today. Consequently, this type of product could have its place in meeting a number of transfusion challenges such as alloimmunization or refractory states. However, culture yields remain low and many hurdles still need to be overcome before considering an application in transfusion. This article reviews the rationale for the production of cultured platelets for transfusion and summarizes the main advances in the field while highlighting its limitations.
血小板是血液中的无核成分。其直径为2至3微米,是血液中最小的成分。虽然它们的主要作用是止血或预防出血,但它们也参与其他功能,如免疫、炎症或肿瘤进展。生物技术的发展以及对调节血小板生物发生机制的认识,使得培养血小板的生产成为当今可行的选择。因此,这类产品在应对一些输血挑战(如同种免疫或难治状态)方面可能会有一席之地。然而,培养产量仍然很低,在考虑将其应用于输血之前,仍有许多障碍需要克服。本文回顾了生产用于输血的培养血小板的基本原理,总结了该领域的主要进展,并突出了其局限性。